Therapeutic landscape of advanced HER2-positive breast cancer in 2022.
Gupta R, Gupta S, Antonios B, Ghimire B, Jindal V, Deol J, Gaikazian S, Huben M, Anderson J, Stender M, Jaiyesimi I.
Gupta R, et al. Among authors: deol j.
Med Oncol. 2022 Oct 12;39(12):258. doi: 10.1007/s12032-022-01849-y.
Med Oncol. 2022.
PMID: 36224475
Review.